Transplanting microbiota into rats is sufficient to induce the symptoms of Alzheimer’s disease
Leah Fogarty reports on memory deficits observed in rats, similar to those found in Alzheimer’s disease, following microbiota modulation.
neurodegeneration
Continue reading
Are chemogenetics really a miracle tool?
Leah Fogarty explores the use of chemogenetics in the treatment of neurological conditions, such as epilepsy, ADHD, and Parkinson’s disease.
What do laboratory mice and Robert De Niro have in common?
Ester Paolocci examines medical ethical complexities, emphasising the need for compassion when treating patients.
Something to consider before eating brains
Ayaka Hogg explains the mysteries behind neurodegeneration caused by prions, misfolded proteins that can spread through the brain.
Shining a light on progressive supranuclear palsy
Ayaka Hogg describes the discovery of progressive supranuclear palsy, and the challenges in treating this neurodegenerative disease.
Treating the old with the new: stem cell therapies for Alzheimer’s disease
Artwork by Matthew Kurnia This article was originally published in The Oxford Scientist Hilary Term 2022 edition, Regeneration. ‘The next great advance in medical care will not be a magical pill, it will be a miraculous cell called the mesenchymal stem cell’. Speaking at a TEDx event in Ashland, Oregon in 2019, American physician Dr…
Yeast on the brain: could fungi be linked to Alzheimer’s Disease?
A fungus that can infect the brain may be the key to understanding Alzheimer’s disease. The blood brain barrier (BBB) is a highly selective barrier that allows very few unwanted substances pass through it. However, there are some bacteria and fungi that have found a way to cross the BBB and cause infections; Candida albicans…